TC
MRVI icon

TownSquare Capital’s Maravai LifeSciences MRVI Stock Holding History

TownSquare Capital’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,498
Closed -$29.8K – 1231
2025
Q1 		$29.8K Sell
13,498
-5,383
-29% -$21.3K ﹤0.01% 1670
2024
Q4 		$103K Buy
+18,881
New +$121K ﹤0.01% 1510

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TownSquare Capital's MRVI Position: Q2 2025 in Review

TownSquare Capital sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 13,498 shares — an estimated $29.8K sold.

TownSquare Capital first reported a position in MRVI in Q4 2024 and held it in 2 quarters. The position peaked at $103K in Q4 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • TownSquare Capital reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 13,498 Maravai LifeSciences shares in Q2 2025, an estimated $29.8K.
  • TownSquare Capital first reported a position in Maravai LifeSciences in Q4 2024 and held it in 2 quarters.
  • TownSquare Capital's Maravai LifeSciences position peaked at $103K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.